Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 20;48(2):102-106.
doi: 10.1016/j.jgg.2021.03.001. Epub 2021 Apr 20.

The challenge of emerging SARS-CoV-2 mutants to vaccine development

Rong Li  1 , Jun Liu  1 , Hui Zhang  2
Affiliations
Review

The challenge of emerging SARS-CoV-2 mutants to vaccine development

Rong Li et al. J Genet Genomics. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mutations in several notable SARS-CoV-2 variants. Schematic of the full-length spike protein of SARS-CoV-2 variants, including G614, D614, B.1.1.7, 501Y.V2, and P.1 lineage. Mutations in the spike protein of these different variants are shown in yellow labeled with the precise position. NTD, N terminal domain; RBD, receptor-binding domain; FP, fusion peptide; HR1, heptad repeat 1; HR2, heptad repeat 2; TM, transmembrane domain.
See this image and copyright information in PMC

References

    1. Buss L.F., Prete C.A., Abrahim C.M.M., Mendrone A., Salomon T., de Almeida-Neto C., França R.F.O., Belotti M.C., Carvalho M.P.S.S., Costa A.G., et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian amazon during a largely unmitigated epidemic. Science. 2021;371:288–292. - PMC - PubMed
    1. Chen R.E., Zhang X., Case J.B., Winkler E.S., Liu Y., VanBlargan L.A., Liu J., Errico J.M., Xie X., Suryadevara N., et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. 2021;27:717–726. - PMC - PubMed
    1. Collier D.A., De Marco A., Ferreira I.A., Meng B., Datir R., Walls A.C., Kemp S.S.A., Bassi J., Pinto D.,, Fregni C.S., et al. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021;593:136–141. - PMC - PubMed
    1. Edara V.V., Floyd K., Lai L., Gardner M., Hudson W., Piantadosi A., Waggoner J.J., Babiker A., Ahmed R., Xie X., et al. Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant. medRxiv. 2021 doi: 10.1101/2021.02.02.21250799. - DOI
    1. Eguia R., Crawford K.H.D., Stevens-Ayers T., Kelnhofer-Millevolte L., Greninger A.L., Englund J.A., Boeckh M.J., Bloom J.D. A human coronavirus evolves antigenically to escape antibody immunity. PLoS Pathog. 2021;17:e1009453. - PMC - PubMed

Publication types

MeSH terms

Substances